TFF Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented thin-film ...
A new vaccine development platform has proven effective in protecting against deadly, hard-to-treat infections caused by multi-drug resistant bacteria, thanks ...
Ridgeback Biotherapeutics and Drug Innovations at Emory (DRIVE) LLC, a not-for-profit biotechnology company wholly owned by Emory University, today announced ...
Aalto Bio Reagents Ltd. signed their first distribution agreement with a Japanese partner, Veritas Corporation, on Oct. 15, 2019. This ...
